Impact of Depression on Health-Related Quality of Life among Skin Cancer Survivors
Main Article Content
Keywords
Abstract
Introduction: Skin cancers are one of the most common cancers in the United States (US). Studies have reported depression to be a common comorbid condition among individuals with skin cancer. This study aimed to evaluate the relationship of depression with health-related quality of life (HRQOL) among individuals with a skin cancer diagnosis.
Methods: A cross-sectional study design using the 2017 Behavioral Risk Factor Surveillance System (BRFSS) data, a nationally representative sample of non-institutionalized US adults, was utilized for the study. Multivariable logistic regression was used to assess the relationship between depression and the HRQOL domains (general health status, physical health, mental health, and activity limitations due to poor physical or mental health) among survivors of skin cancer.
Results: Comorbid depression was identified in 20% of skin cancer survivors. After adjusting for covariates, skin cancer survivors with depression had higher odds of having poor general health status (Odds Ratio [OR] = 1.67, 95% Confidence Interval [CI] 1.41-1.98) as compared to skin cancer survivors without depression. Skin cancer survivors with depression also had greater odds of having poor physical HRQOL (OR = 1.82, 95% CI 1.53-2.15), poor mental HRQOL (OR = 6.38, 95% CI 5.26-7.74), and activity limitations (OR = 2.42, 95% CI 2.03-2.89) as compared to those without depression.
Conclusion: This study highlights the significant negative impact of comorbid depression on HRQOL in a nationally representative sample of skin cancer survivors, and serves as evidence for the need for more active surveillance and management of depression in this population.
References
2. American Cancer Society. Key Statistics for Melanoma Skin Cancer. Available at https://www.cancer.org/cancer/melanoma-skin-cancer/about/key-statistics.html. Accessed March 7, 2019.
3. Cornish D, Holterhues C, Poll-Franse VD, V L, Coebergh JW, Nijsten T. A systematic review of health-related quality of life in cutaneous melanoma. Ann Oncol. 2009;20(suppl_6):vi51-vi58. doi:10.1093/annonc/mdp255
4. Cormier JN, Ross MI, Gershenwald JE, et al. Prospective assessment of the reliability, validity, and sensitivity to change of the functional assessment of cancer Therapy-Melanoma questionnaire. Cancer. 2008;112(10):2249-2257. doi:10.1002/cncr.23424
5. Cormier JN, Askew RL. Assessment of Patient-Reported Outcomes in Patients with Melanoma. Surg Oncol Clin. 2011;20(1):201-213. doi:10.1016/j.soc.2010.09.002
6. Hamel J-F, Pe M, Coens C, et al. A systematic review examining factors influencing health related quality of life among melanoma cancer survivors. Eur J Cancer. 2016;69:189-198. doi:10.1016/j.ejca.2016.10.008
7. Cohen L, Parker PA, Sterner J, de Moor C. Quality of life in patients with malignant melanoma participating in a phase I trial of an autologous tumour-derived vaccine. Melanoma Res. 2002;12(5):505.
8. Rhee JS, Loberiza FR, Matthews BA, Neuburg M, Smith TL, Burzynski M. Quality of Life Assessment in Nonmelanoma Cervicofacial Skin Cancer. The Laryngoscope. 2003;113(2):215-220. doi:10.1097/00005537-200302000-00004
9. Chren M-M. The Skindex Instruments to Measure the Effects of Skin Disease on Quality of Life. Dermatol Clin. 2012;30(2):231-236. doi:10.1016/j.det.2011.11.003
10. Hawkins DM, Jacobsen G, Johnson CC, Lim HW, Eide MJ. Self-reported quality of life after skin cancer in young adults. J Dermatol Treat. 2015;26(4):357-360. doi:10.3109/09546634.2014.991671
11. Gaulin C, Sebaratnam DF, Fernández-Peñas P. Quality of life in non-melanoma skin cancer. Australas J Dermatol. 2015;56(1):70-76. doi:10.1111/ajd.12205
12. Trask PC, Paterson AG, Griffith KA, Riba MB, Schwartz JL. Cognitive-behavioral intervention for distress in patients with melanoma. Cancer. 2003;98(4):854-864. doi:10.1002/cncr.11579
13. Kasparian NA, McLoone JK, Butow PN. Psychological Responses and Coping Strategies Among Patients With Malignant Melanoma: A Systematic Review of the Literature. Arch Dermatol. 2009;145(12):1415-1427. doi:10.1001/archdermatol.2009.308
14. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10(1):19-28. doi:10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.0.CO;2-6
15. Kasparian NA. Psychological stress and melanoma: Are we meeting our patients’ psychological needs? Clin Dermatol. 2013;31(1):41-46. doi:10.1016/j.clindermatol.2011.11.005
16. Trask PC, Paterson AG, Hayasaka S, Dunn RL, Riba M, Johnson T. Psychosocial Characteristics of Individuals With Non–Stage IV Melanoma. J Clin Oncol. 2001;19(11):2844-2850. doi:10.1200/JCO.2001.19.11.2844
17. Hoffman KE, McCarthy EP, Recklitis CJ, Ng AK. Psychological Distress in Long-term Survivors of Adult-Onset Cancer: Results From a National Survey. Arch Intern Med. 2009;169(14):1274-1281. doi:10.1001/archinternmed.2009.179
18. Brown LF, Kroenke K, Theobald DE, Wu J, Tu W. The association of depression and anxiety with health‐related quality of life in cancer patients with depression and/or pain. Psycho‐Oncology. 2010;19(7):734-741. doi:10.1002/pon.1627
19. Kroenke K, Theobald D, Wu J, Loza JK, Carpenter JS, Tu W. The Association of Depression and Pain with Health-Related Quality of Life, Disability, and Health Care Use in Cancer Patients. J Pain Symptom Manage. 2010;40(3):327-341. doi:10.1016/j.jpainsymman.2009.12.023
20. Reyes-Gibby CC, Anderson KO, Morrow PK, Shete S, Hassan S. Depressive Symptoms and Health-Related Quality of Life in Breast Cancer Survivors. J Womens Health. 2011;21(3):311-318. doi:10.1089/jwh.2011.2852
21. Centers for Disease Control and Prevention. Measuring Healthy Days: Population Assessment of Health-Related Quality of Life. Atlanta, GA.: CDC; 2000.
22. Joshi N, Khanna R, Shah RM. Relationship Between Depression and Physical Activity, Disability, Burden, and Health-Related Quality of Life Among Patients with Arthritis. Popul Health Manag. 2014;18(2):104-114. doi:10.1089/pop.2014.0062
23. Zhao G, Okoro CA, Li J, White A, Dhingra S, Li C. Current depression among adult cancer survivors: Findings from the 2010 Behavioral Risk Factor Surveillance System. Cancer Epidemiol. 2014;38(6):757-764. doi:10.1016/j.canep.2014.10.002
24. Gibertini M, Reintgen DS, Baile WF. Psychosocial aspects of melanoma. Ann Plast Surg. 1992;28(1):17-21.
25. Linden W, Vodermaier A, MacKenzie R, Greig D. Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141(2):343-351. doi:10.1016/j.jad.2012.03.025
26. Tas F, Karabulut S, Guveli H, et al. Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients. Asian Pac J Cancer Prev APJCP. 2017;18(2):369-373. doi:10.22034/APJCP.2017.18.2.369
27. Faller H, Brähler E, Härter M, et al. Performance status and depressive symptoms as predictors of quality of life in cancer patients. A structural equation modeling analysis. Psychooncology. 2015;24(11):1456-1462. doi:10.1002/pon.3811
28. Loge JH, Abrahamsen AF, Ekeberg Ø, Kaasa S. Fatigue and Psychiatric Morbidity Among Hodgkin’s Disease Survivors. J Pain Symptom Manage. 2000;19(2):91-99. doi:10.1016/S0885-3924(99)00148-7
29. Ahlberg K, Ekman T, Wallgren A, Gaston-Johansson F. Fatigue, psychological distress, coping and quality of life in patients with uterine cancer. J Adv Nurs. 2004;45(2):205-213. doi:10.1046/j.1365-2648.2003.02882.x
30. Chan JYK, Lua LL, Starmer HH, Sun DQ, Rosenblatt ES, Gourin CG. The relationship between depressive symptoms and initial quality of life and function in head and neck cancer. The Laryngoscope. 2011;121(6):1212-1218. doi:10.1002/lary.21788
31. Inhestern L, Beierlein V, Bultmann JC, et al. Anxiety and depression in working-age cancer survivors: a register-based study. BMC Cancer. 2017;17(1):347. doi:10.1186/s12885-017-3347-9
32. Andersen BL, Rowland JH, Somerfield MR. Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation. J Oncol Pract. 2015;11(2):133-134. doi:10.1200/JOP.2014.002311
33. Strong V, Waters R, Hibberd C, et al. Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. The Lancet. 2008;372(9632):40-48. doi:10.1016/S0140-6736(08)60991-5
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.